Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: The study tracked about 20,000 severely obese patients with Type 2 diabetes. Those who had weight loss surgery had a 40 percent lower chance of developing a heart attack or stroke in the five years following surgery compared to those who got usual care with diabetes medicines or insulin. For every 1,000 patients in the study who had surgery there were roughly 20 heart attacks or strokes compared to 40 such events per 1,000 who got regular care. More than 30 million Americans have diabetes, mostly Type 2 where the body loses the ability to produce or use insulin to turn food into energy. Other research has shown obesity surgery can reverse and even prevent diabetes. Taken together, it means doctors should discuss weight loss surgery more often, said study co-author Dr. David Arterburn of Kaiser Permanente Washington Health Research Institute in Seattle. Doctors usually mention insulin and pills, “but it’s not always brought up that weight loss surgery is another available treatment option,” Arterburn said. Researchers analyzed records from four U.S. health care systems: HealthPartners in Minnesota and Kaiser Permanente in Washington state, Northern California and Southern California. Results were published Tuesday in the Journal of the American Medical Association. The study can’t prove cause and effect because patients weren’t randomly assigned to get surgery. The researchers tried to match patients for gender, age, blood sugar levels and other factors. But other things they didn’t account for could have contributed to the surgery patients’ better results. Everyone in the study had a BMI, or body mass index, of at least 35. For instance, someone who is 5-foot-8-inches and weighs 230 pounds has a BMI of 35. Of the more than 5,300 who had surgery, most had gastric bypass, the most common type of stomach-shrinking operation. Some had gastric sleeve or gastric band procedures. The rest, nearly 15,000 people, had usual care. Obesity surgery can cost $20,000 to $25,000. Insurers are increasingly covering it, but some impose strict limits. The new findings suggest insurance coverage should be expanded for the right patients, Dr. Sayeed Ikramuddin of the University of Minnesota wrote in an accompanying editorial. Surgery is thought to help by affecting hormones, gut bacteria and other substances that affect how the body handles insulin and blood sugar. Weight loss without surgery also helps, but is difficult for many people to achieve. Most weight loss surgery today is done through small incisions. The dangers are similar to other surgeries, including a small chance of life-threatening complications, and some people need to have their surgeries repeated. ___ Follow AP Medical Writer Carla K. Johnson on Twitter: @CarlaKJohnson ___ The Associated Press Health &amp; Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Claim: Obesity surgery may lower heart attack danger in diabetics.
[EX A]: Obesity surgery may dramatically lower the danger of heart attacks and strokes in patients with diabetes, new research suggests, reinforcing evidence that benefits extend beyond weight loss.

[EX Q]: Paragraph: After nearly disappearing in the United States, the bloodsucking pests have made a comeback in recent years, quickly infesting apartment buildings and stubbornly resisting common insecticides. The city of New York alone spends as much as $40 million a year in bedbug control. A study of bedbug genetics presented on Tuesday at the American Society of Tropical Medicine and Hygiene meeting in Philadelphia now suggests why. A team of entomologists led by Coby Schal and Ed Vargo of North Carolina State University studied the genes of bedbugs infesting three multistory apartment buildings in North Carolina and New Jersey and found very low genetic diversity — meaning most of them were very close relatives. They were so close in fact that the team suspects it may have taken just one or two founder insects to start an entire infestation. “We find that bedbug infestations basically start from a very small number of individuals,” Schal said in a telephone interview. “A single mated female bedbug starts the infestation. She gives rise to offspring and those offspring mate with each other and with their mother,” he said. “This is different from many animals,” he said, mostly because close inbreeding can result in genetic deformities, adding, “In humans, it is taboo.”   But he said there are some animals that can withstand such close inbreeding without experiencing detrimental effects including cockroaches. Schal said this may be a trait of insects that have evolved an association with humans and rely on them to get from place to place. Typically this happens when humans bring infested furniture into their homes, and he warns people to inspect second-hand furniture carefully. “There is a myth out there that bedbugs get transported on people,” Schal said. Unlike ticks, the wingless, reddish-brown insects stay attached to people for a blood meal for just 5 to 10 minutes, he said. “The chances that a person is carrying bedbugs on them is quite low.”   According to the U.S. Centers for Disease Control and Prevention, bedbugs do not carry disease, but their bites can cause severe itching and a whole lot of anxiety. Schal said his findings are not likely to lead to new insecticides for bedbugs, but they do underscore the need to move fast once bedbugs are detected. “If you don’t deal with them early they can spread thorough   a building very quickly,” he said. Claim: All in the family: Inbreeding key to bedbug spread.
[EX A]: Inbreeding may be the secret to the bedbug’s success, U.S. researchers said on Tuesday.

[EX Q]: Paragraph: Mas will not be investigated for the graver charge of manslaughter, as was expected, but does now face criminal charges which carry longer sentences than those he faces in a fraud case expected to go to trial around October. He was released on bail of 100,000 euros ($131,600), banned from leaving the country and from meeting former executives of his now defunct company Poly Implant Prothese (PIP). “We are satisfied that Mr Mas could explain himself to a judge,” his lawyer Yves Haddad said on iTele television. “This is a relief for him.”   “On the charge of involuntary homicide, the judge decided that for now there is no link,” Haddad said. In the first arrests since the two-year-old scandal made headlines worldwide in December, Mas and a second PIP executive were seized at their homes in southern France just after dawn. Women who have been campaigning against PIP since French authorities banned its products nearly two years ago welcomed the move as giving them a sense that the law was now in action:   “It’s been too long,” said Murielle Ajellio, who heads an association for women with implants. Up to now, she said: “You feel like you’re fighting against the wind.”   French authorities have been criticized for being slow to react to a case that has sown fear among tens of thousands of women who carry PIP implants. French inspectors ordered them off the market in March 2010, due to concerns over their quality. But only last month did officials in Paris recommend their surgical removal, drawing attention to the problem for patients worldwide who had been fitted with products from the company, which was at one time the third biggest global supplier. Lawyers for women in France who have filed complaints over PIP implants welcomed the arrests and said there must be no escaping justice for the 72-year-old Mas, who has been quoted as deriding those suing him as being motivated only by money. “This is a comfort for the victims,” said Laurent Gaudon, whose clients are pursuing PIP and surgeons who used its implants for fraud. “It’s the feeling that justice is advancing and they have not been forgotten. It’s the assurance that the guilty are at last going to be held accountable.”   Philippe Courtois, who represents 1,300 people with PIP implants, said Mas should not be freed pending any trial. Mas and PIP’s former chief executive Claude Couty were questioned at home, as police conducted searches. They were then moved to police custody in the Mediterranean port city of Marseille, under the orders of prosecutor Jacques Dallest. PIP enjoyed years of success with international sales, but behind the scenes employees, and Mas himself, have admitted to hiding from certification agencies the fact they were using cheap, industrial silicone, not approved for medical use. Health authorities in France and elsewhere have stressed that PIP’s products carry no proven link to cancer, but surgeons report that they have abnormally high rupture rates. Responses to the problem have varied among different foreign authorities. Thursday’s arrests follow an investigation opened in Marseille, close to PIP’s former premises, on December 8 after the death from cancer in 2010 of a woman with PIP implants. Mas and Couty can be held for up to 48 hours while a judge decides whether to open a formal probe and, if so, what bail conditions, if any, to set. A trial date could be years away, given the extent of inquiry required, but the bodily harm case could make it harder for Mas to avoid appearing in court later this year on other charges of fraud and deception. That latter case targets half a dozen former PIP executives and could also carry prison terms for them of several years. It has dragged on as investigators have had to quiz up to 2,700 women who have filed complaints over PIP implants. Mas, who sold some 300,000 implants around the world, has acknowledged that he used unapproved silicone but dismissed fears that it constituted a health risk. Earlier in January, leaks from a police document showed Mas admitting to lying about the quality of PIP’s implants and describing the women filing complaints against him as just seeking money. The comments sparked public anger against him. PIP closed down in March 2010 after regulators discovered it was using a non-approved, industrial silicone gel, and pulled its implants off the market. Last month, the French government advised women with PIP implants to have them removed, and said it would pay for the operations in France, sparking alarm around the world. Officials in several other countries, including Britain and Brazil, have asked women to visit their doctors for checks. France has called for tighter European Union regulations on medical devices in wake of the PIP affair, saying suppliers of prosthetics should require the same sort of authorization as manufacturers of prescription medicines. Claim: French implant boss released, faces bodily harm charge.
[EX A]:
Jean-Claude Mas, the Frenchman who sparked a global health scare by selling substandard breast implants, was released from police custody on Friday and faces a charge of causing bodily harm, his lawyer said.